Acting on minimal residual disease in ALL

Michael Rytting

doi:10.1016/S1470-2045(14)70280-3

Acting on minimal residual disease in ALL

Michael Rytting

Pediatrics

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	777-778
Number of pages	2
Journal	The lancet oncology
Volume	15
Issue number	8
DOIs	https://doi.org/10.1016/S1470-2045(14)70280-3
State	Published - Jul 2014

ASJC Scopus subject areas

Oncology

Access to Document

10.1016/S1470-2045(14)70280-3

Cite this

@article{067b930a2f944636849de4d0ee66cec9,

title = "Acting on minimal residual disease in ALL",

author = "Michael Rytting",

year = "2014",

month = jul,

doi = "10.1016/S1470-2045(14)70280-3",

language = "English (US)",

volume = "15",

pages = "777--778",

journal = "The lancet oncology",

issn = "1470-2045",

publisher = "Lancet Publishing Group",

number = "8",

}

TY - JOUR

T1 - Acting on minimal residual disease in ALL

AU - Rytting, Michael

PY - 2014/7

Y1 - 2014/7

UR - http://www.scopus.com/inward/record.url?scp=84903514365&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903514365&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(14)70280-3

DO - 10.1016/S1470-2045(14)70280-3

M3 - Comment/debate

C2 - 24924992

AN - SCOPUS:84903514365

SN - 1470-2045

VL - 15

SP - 777

EP - 778

JO - The lancet oncology

JF - The lancet oncology

IS - 8

ER -

Acting on minimal residual disease in ALL

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this